Cocrystal Pharma, Inc. - Form 8-K Summary
Business Context and Reporting Period
This is a Current Report (Form 8-K) filed by Cocrystal Pharma, Inc., a Delaware corporation, on April 25, 2016. The report discloses a Regulation FD event involving the issuance of a press release on the same date.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely to announce the release of a press release and does not contain financial statements or operational data.
Material Changes
No material changes to financial performance or operations are detailed in this filing. The only reported event is the public disclosure of information via a press release.
Guidance, Outlook, and Risks
The filing does not contain management commentary, guidance, outlook, or specific risk factors. The content of the referenced press release (Exhibit 99.1) is not included in the provided text, so no specific details regarding the company's outlook or contingencies can be summarized.
Key Facts for Investor Verification
- Verify the content of the press release dated April 25, 2016, which is attached as Exhibit 99.1 to the full filing.
- Confirm whether the press release contains material non-public information regarding clinical trials, partnerships, or financial updates.
- Note that this 8-K filing itself contains no quantitative financial data.